Visit Dr. James P. King Jr., an ent / otolaryngologist in Galax, VA. Are you Dr. King? Sign up for MD.com. Visit cloudflare.com for more information. Please try again in a few minutes. Cloudflare Ray ID: 7c6ddc32ca9bb984 Performance & security by Cloudflare
Richard J. Castriotta, MD, FCCP, Basil A. Eldadah, MD, PhD, ... MD, William R. Hazzard, MD, James P. Kiley, PhD, Talmadge E. King, Jr, MD, FCCP, ... Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer. Chest. 2010 Sep; 138(3): 693–703. doi: 10.1378/chest.09-3006 PMCID: PMC4694103PMID: 20822991 Workshop on Idiopathic Pulmonary Fibrosis in Older Adults Richard J. Castriotta, MD, FCCP, Basil A. Eldadah, MD, PhD, W. Michael Foster, PhD, Jeffrey B. Halter, MD, William R. Hazzard, MD, James P. Kiley, PhD, Talmadge E. King, Jr, MD, FCCP, Frances McFarland Horne, PhD, Susan G. Nayfield, MD, Herbert Y. Reynolds, MD, Kenneth E. Schmader, MD, Galen B. Toews, MD, FCCP, and Kevin P. High, MD* Idiopathic pulmonary fibrosis (IPF), a heterogeneous disease with respect to clinical presentation and rates of progression, disproportionately affects older adults. The diagnosis of IPF is descriptive, based on clinical, radiologic, and histopathologic examination, and definitive diagnosis is hampered by poor interobserver agreement and lack of a consensus definition. There are no effective treatments. Cellular, molecular, genetic, and environmental risk factors have been identified for IPF, but the initiating event and the characteristics of preclinical stages are not known. IPF is predominantly a disease of older adults, and the processes underlying normal aging might significantly influence the development of IPF. Yet, the biology of aging and the principles of medical care for this population have been typically ignored in basic, translational, or clinical IPF research. In August 2009, the Association of Specialty Professors, in collaboration with the American College of Chest Physicians, the American Geriatrics Society, the National Institute on Aging, and the National Heart, Lung, and Blood Institute, held a workshop, summarized herein, to review what is known, to identify research gaps at the interface of aging and IPF, and to suggest priority areas for future research. Efforts to answer the questions identified will require the integration of geriatrics, gerontology, and pulmonary research, but these efforts have great potential to improve care for patients with IPF.
Dr. James Cappon is board certified in pediatrics and pediatric critical care who treats kids and teens in Orange County. He is also the hospital's director ... Skip to main contentSkip to choc.org search Home » Providers » Critical Care » Cappon, James P. MD Dr. James P. Cappon, Pediatric Critical Care Dr. James Cappon is board certified in pediatrics and pediatric critical care medicine and provides the full range of tertiary-level critical care procedures, with expertise in mechanical ventilation and management of respiratory failure. He sees patients at CHOC Hospital in Orange. Dr. Cappon serves as Chief Quality and Safety Officer. Prior to joining CHOC, Dr. Cappon attended medical school at the University of New Mexico School of Medicine in Albuquerque. He completed his residency training at Harbor-UCLA Medical Center in Torrance, California, and his fellowship training in pulmonology and critical care at Harbor-UCLA Medical Center, CHOC and the Martin Luther King Jr. Medical Center, Department of Pediatrics, Division of Pediatric Critical Care/Pulmonology. Patient safety, quality improvement, pediatric transport James P Cappon MD is on staff at CHOC Hospital in Orange . Dr. Cappon is dedicated to studying best practices in patient safety and quality improvement. His past and current research has focused on adverse event triggers in pediatric intensive care units; improved assessment, triage and safety for pediatric transport; and reducing catheter-associated bloodstream infections. Dr. Cappon is currently co-investigator in eight studies at CHOC, including studies looking at genomic analysis of pediatric systemic inflammatory response syndrome, sedation management in pediatric patients with acute respiratory failure, and therapeutic hypothermia after pediatric cardiac arrest. He is involved in several studies dealing with influenza and a prospective cohort study looking at pertussis in U.S. children.
---
James Wu, MD. Medical Specialties: Pediatric Emergency Medicine. Mary Bridge Children's Emergency Department · 317 Martin Luther King Jr Way, Tacoma, ... Find a Doctor > James Wu, MD Medical Specialties: Pediatric Emergency Medicine Mary Bridge Children's Emergency Department 317 Martin Luther King Jr Way, Tacoma, WA 98405 © 2023 Mary Bridge Children's. All Rights Reserved. Website Privacy | Terms of Use | Read our patient nondiscrimination policy. Website Design and Development by SiteCrafting.